Literature DB >> 23358962

Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?

B Bourre, R Lefaucheur, C Girault.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23358962     DOI： 10.1007/s13760-013-0178-6

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  2 in total

1.  Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.

Authors:  Markus Krumbholz; Ulrich Hofstadt-van Oy; Klemens Angstwurm; Ingo Kleiter; Sven Jarius; Friedemann Paul; Orhan Aktas; Grete Buchholz; Peter Kern; Andreas Straube; Tania Kümpfel
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 2.  Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.

Authors:  Masoud Etemadifar; Mehri Salari; Omid Mirmosayyeb; Mehdi Serati; Roham Nikkhah; Mozhde Askari; Emad Fayyazi
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.